Meet the BOARD
Teresa Brierley
President
Teresa has worked in the Diocese of Maitland-Newcastle since 2005. In her present role, as Director of Pastoral Ministries, Teresa supports the Bishop as a member of the Diocesan Leadership Group in pastoral matters across the diocese – parishes, chaplaincies, pastoral planning, diocesan councils etc.
Prior to this she served the Catholic Church as a Pastoral Associate, as a secondary school Religious Education Co-ordinator, maths and science teacher. She began her professional career as a Biomedical Scientist working in hospital pathology. She is married to Allen and they have five children and a number of grandchildren.
MTh; BSc (App); Dip. Ed; Dip RE; Dip Ed (Leadership), Grad. Cert. (Mission & Culture)
Carolyn Boyd
Vice President
Carolyn Boyd has over 40 years’ experience with CF, having been diagnosed with CF in 1971 and undergoing a successful double lung transplant in 1994.
Carolyn works as a Personal Assistant for an Associate Clinical Professor of Endocrinology, and for a Doctor of Immunology. She joined the Board of CFWA in 2010 being elected as Vice President in 2017.
Carolyn is a regular speaker and advocate for people living with CF and a tireless fundraiser. Carolyn was elected as President of CFWA in 2018 and joined CFA in the same year.
Scott Lancaster
Vice President
Scott joined the board of Cystic Fibrosis Australia early 2023 and served as its chair for 18 months from May 2023 until November 2024. He has a long association with the CF community, having also been on the board of Cystic Fibrosis Tasmania since 2001, after his first child was born with CF in 1999. He has served as CF Tasmania’s Secretary and Treasurer, and as its President since April 2010.
In addition to having completed a Bachelor of Business, Scott is a Graduate Member of the Australian Institute of Company Directors, after undertaking the Company Directors’ Diploma. He was a Director of the credit union Connect Financial in 2007-08, before it merged with Island State Credit Union to form MyState Financial, and has been a member of the Board of Management at Glenview Community Services, an aged-care provider in Hobart’s northern suburbs, since October 2008, and is the current Chair of Glenview.
Scott has worked in sales roles within the IT industry, marketing roles in the retail and energy sectors, as well as in the banking/financial sector. He’s also worked in the Tasmanian public service as a policy analyst with the Department of Treasury and Finance and the former Department of Primary Industries Parks Water and Environment. For the past 10 years Scott has worked as a regulatory policy analyst for the electricity network operator TasNetworks.
Paulina Manenica
Treasurer
Paulina Manenica is a seasoned executive and purpose-led leader with a strategic career spanning finance, operations, and corporate governance across government, private, and not-for-profit sectors. She brings to the board of Cystic Fibrosis Australia a rare combination of financial expertise, operational insight, and a deep commitment to community impact.
Currently serving as the Executive Manager of Social Enterprises at the Y Canberra Region, Paulina leads two key portfolios: student accommodation and Health and Wellbeing. In this role, she drives strategic direction, operational excellence, and the delivery of high-impact community programs aligned with the Y’s mission to support young people aged 0–30 and build inclusive, resilient communities. She is known for her collaborative and transparent leadership style, prioritising clear communication, accountability, and the empowerment of teams to thrive.
Prior to this, Paulina held the role of Chief Financial and Operations Officer at the National Zoo & Aquarium and Jamala Wildlife Lodge, where she played a pivotal role in guiding the organisation through the COVID-19 pandemic. Her leadership during this time supported financial sustainability, strategic growth, and operational efficiency across a workforce of more than 200 staff.
Her earlier roles at Defence Housing Australia (DHA) included serving as Project Director for a $250 million government housing stimulus initiative and as National Customer Service Manager, where she led the organisation to national recognition for service excellence. She also contributed to DHA’s growth into a $1.5 billion enterprise through her strategic and financial acumen.
Paulina’s career began at Hindmarsh, where she led finance teams through complex audits and ASX readiness. Her long-term support for the Missionaries of God’s Love (MGL) further underscores her commitment to ethical leadership and community governance.
A qualified Chartered Accountant, Paulina holds a Bachelor of Commerce and is a graduate of the AICD Company Directors Course. She currently sits on several boards, including Cystic Fibrosis ACT and Cystic Fibrosis Australia, where she continues to advocate for positive, sustainable change for individuals and families living with cystic fibrosis.
Nettie Burke
Director
Nettie spent almost three decades in corporate advertising working at high profile agencies including Saatchi and Saatchi and Adcorp Australia.
Nettie has a successful track record in liaising at the highest level of corporate management and government, both in Australia and the United Kingdom and was formally a Board Member of Fashion Targets Breast Cancer, Muscular Dystrophy NSW and The Kid’s Cancer Project.
As the CEO of Cystic Fibrosis Australia, Nettie was first and foremost a passionate advocate for the cystic fibrosis community. During her tenue she focused on gaining access to cutting edge drugs and treatments, research, supporting better mental health services and reducing the burden of the disease.
Nettie spearheaded key initiatives at CFA, including partnership development, research priority setting, consumer engagement and clinical improvement.
Nettie has recently established Good-Works Advocacy to strengthen the consumer voice in health policy, support health equity for all Australians and promote the use of real world evidence in the HTA system.
Peter Summers
Director
Peter brings over 40 years of board and executive leadership experience across private enterprise, government, and the not-for-profit sectors in both Australia and New Zealand. A Fellow of the Australian Institute of Company Directors and Chartered Director, Peter has chaired numerous boards, including IQMS Australasia, where he led quality and compliance innovation. He has advised on governance, business improvement, and ISO-standard compliance systems across multiple industries.
Appointed by the Minister of Defence, Peter chaired the SA Defence Reserves Board and served on the National Council. His community leadership includes roles such as President and Chair of Cystic Fibrosis South Australia and Vice Chancellor of the Order of St John Knights Hospitaller. He also held key leadership positions with the Naval, Military and Air Force Club of SA, Australia Day Council, and ANZAC Day Committee.
A former Army Reservist and long-time Cadet Commander, Peter has dedicated decades to youth leadership and public service, earning national recognition for his contributions.
OAM, CJSJ
FAICD, DipCD, MAOQ, Assoc. Dip Marketing
Michael O'Neill
Director
Michael brings extensive experience across government, private, and not-for-profit sectors. He is currently a Senior Director at Metro South Health, leading Corporate Services. His previous roles include Director of the Queensland Tissue Bank and management consulting with a global professional services firm, where he specialised in clinical service redesign, efficiency improvements, and operating model transformation.
Michael holds qualifications in Health Science and Business from the Queensland University of Technology, giving him a strong understanding of the opportunities and constraints faced by both healthcare and business environments. He thrives on complex challenges, bringing strategic and practical solutions to the table.
Living with Cystic Fibrosis and having received a life-saving lung transplant 13 years ago, Michael is a strong advocate for the CF community. He is married with two children, aged 9 and 7.
Matthew Dark
Director
Matthew brings extensive experience across state and federal government, as well as the not-for-profit sector. He has a strong background in large-scale digital health implementations and national program management, with a focus on improving data, technology, and service outcomes in complex healthcare environments.
He holds a Bachelor degree in Exercise and Nutrition Science Science and a Master of Public Health from the University of Queensland (UQ) as well as a Master of Health Management and Leadership from the University of New South Wales (UNSW). Matthew has also completed his Certified Health Informatician Australasia (CHIA) certification and several project management qualifications. These qualifications have equipped him with the skills and perspective to support his passion for improving healthcare across Australia.
Matthew is deeply committed to supporting Cystic Fibrosis Australia’s mission through strategic oversight and a drive for system-wide impact. His connection to cystic fibrosis is also personal, with a family member diagnosed with the condition – an experience that strengthens his dedication to advancing better outcomes for the CF community.
Matthew lives in Newcastle, NSW with his wife and two children.
Sabrina Barbic
Director
Sabrina Barbic is a senior commercial leader with a global career in the pharmaceutical and life sciences sectors, currently serving as Senior Director at Thermo Fisher Scientific. With extensive experience across Australia, Europe, and the United States, she has a strong track record of driving growth, leading high-performing teams, and successfully launching innovative therapies in complex and competitive markets.
Sabrina brings deep expertise in rare diseases, most recently Cystic Fibrosis, having spent 3.5years as Country Manager for Vertex. Sabrina also has a passion for purpose-driven leadership, collaboration, and building engaged, high-impact organizations. She has held executive roles at Vertex Pharmaceuticals, Gilead Sciences, and Bristol-Myers Squibb, delivering transformational results across multiple therapeutic areas and geographies.